Serge Goldner
Algemeen Directeur bij CORETECH 5
Profiel
Serge Goldner was the founder of Cukierman & Co. Life Sciences, founded in 2006, where he held the title of Managing Partner.
He is also the founder of Coretech 5 SA, founded in 2014, where he currently holds the titles of Chairman & Chief Executive Officer.
Mr. Goldner's former job was as Chief Financial Officer at Immune Pharmaceuticals, Inc.
Actieve functies van Serge Goldner
Bedrijven | Functie | Begin |
---|---|---|
CORETECH 5 | Algemeen Directeur | 14-07-2014 |
Eerdere bekende functies van Serge Goldner
Bedrijven | Functie | Einde |
---|---|---|
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Oprichter | - |
IMMUNE PHARMACEUTICALS, INC. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CORETECH 5 | Process Industries |
Bedrijven in privébezit | 2 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Finance |